WO2003015699A3 - Topical compositions and methods for treating pain - Google Patents
Topical compositions and methods for treating pain Download PDFInfo
- Publication number
- WO2003015699A3 WO2003015699A3 PCT/US2002/025871 US0225871W WO03015699A3 WO 2003015699 A3 WO2003015699 A3 WO 2003015699A3 US 0225871 W US0225871 W US 0225871W WO 03015699 A3 WO03015699 A3 WO 03015699A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- topical compositions
- treating pain
- pain
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA04001368A MXPA04001368A (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain. |
IL16038802A IL160388A0 (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
JP2003520460A JP2005501844A (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for the treatment of pain |
EP02770398A EP1438020A4 (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
KR10-2004-7002327A KR20040053112A (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
CA2457780A CA2457780C (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
NZ531547A NZ531547A (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
AU2002335635A AU2002335635B2 (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
IL160388A IL160388A (en) | 2001-08-17 | 2004-02-12 | Emulsions comprising amitriptyline and ketamine |
HK06109763.0A HK1089364A1 (en) | 2001-08-17 | 2006-09-01 | Topical compositions and methods for treating pain |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/931,293 | 2001-08-17 | ||
US09/931,293 US6638981B2 (en) | 2001-08-17 | 2001-08-17 | Topical compositions and methods for treating pain |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003015699A2 WO2003015699A2 (en) | 2003-02-27 |
WO2003015699A3 true WO2003015699A3 (en) | 2003-08-14 |
Family
ID=25460543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/025871 WO2003015699A2 (en) | 2001-08-17 | 2002-08-14 | Topical compositions and methods for treating pain |
Country Status (13)
Country | Link |
---|---|
US (2) | US6638981B2 (en) |
EP (1) | EP1438020A4 (en) |
JP (1) | JP2005501844A (en) |
KR (1) | KR20040053112A (en) |
CN (1) | CN100496472C (en) |
AR (1) | AR035131A1 (en) |
AU (1) | AU2002335635B2 (en) |
CA (1) | CA2457780C (en) |
HK (1) | HK1089364A1 (en) |
IL (2) | IL160388A0 (en) |
MX (1) | MXPA04001368A (en) |
NZ (1) | NZ531547A (en) |
WO (1) | WO2003015699A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10179159B2 (en) * | 1999-10-22 | 2019-01-15 | Scott Wepfer | Topical anesthetic formulation |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
US20050013853A1 (en) * | 2000-11-29 | 2005-01-20 | Irit Gil-Ad | Anti-proliferative drugs |
IL139975A0 (en) * | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
AU2003213009A1 (en) * | 2002-02-12 | 2003-09-04 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
PT1513532E (en) * | 2002-06-10 | 2007-05-31 | Euro Celtique Sa | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
CN1214785C (en) * | 2002-08-27 | 2005-08-17 | 孙丽琴 | Yanming qingsong plaster and it preparation method |
US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
US20040106681A1 (en) * | 2002-10-03 | 2004-06-03 | Cypress Bioscience, Inc. | Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
KR101108439B1 (en) | 2002-10-25 | 2012-01-31 | 포믹스 리미티드 | Cosmetic and pharmaceutical foam |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20040138204A1 (en) * | 2002-10-30 | 2004-07-15 | Harrington James Frederick | Compositions and methods for pain reduction |
JP2006514934A (en) | 2002-11-26 | 2006-05-18 | アレックザ ファーマシューティカルズ, インコーポレイテッド | Use of loxapine or amoxapine for the manufacture of drugs for the treatment of pain |
EP1610742B1 (en) | 2003-04-10 | 2015-01-21 | Neurogesx, Inc. | Uses and compositions for administration of capsaicin |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
JP2007516404A (en) | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ, インコーポレイテッド | Optically or electrically ignited built-in heating unit and drug supply unit using the same |
US20050095277A1 (en) * | 2003-06-25 | 2005-05-05 | Binnur Ozturk | Neuropathy cream |
US20040265364A1 (en) * | 2003-06-25 | 2004-12-30 | Binnur Ozturk | Neuropathy cream |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
DE10338174A1 (en) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal drug formulations with drug combinations for the treatment of Parkinson's disease |
US20050075407A1 (en) * | 2003-08-25 | 2005-04-07 | Foamix Ltd. | Foam incorporating eutetic mixture |
US20050113365A1 (en) * | 2003-11-10 | 2005-05-26 | Sir Isaac Newton Enterprises Llc | Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome |
US20060148781A1 (en) * | 2003-11-10 | 2006-07-06 | Lundeen James E | Method and medicine for treating gastrointestinal disorder in a non-human mammal |
US20060148783A1 (en) * | 2003-11-10 | 2006-07-06 | Lundeen James E | Method and medicine for treating gastrointestinal disorder including fecal incontinence |
WO2005058319A1 (en) * | 2003-12-16 | 2005-06-30 | Cnsbio Pty Ltd | Methods and compositions |
AU2004298288B2 (en) * | 2003-12-16 | 2011-06-30 | Relevare Aust. Pty Ltd | Methods and compositions |
WO2005082054A2 (en) * | 2004-02-26 | 2005-09-09 | Sosei Co., Ltd. | Combinations for the treatment of fungal infections |
US20060063802A1 (en) | 2004-03-29 | 2006-03-23 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US8268866B2 (en) * | 2004-03-29 | 2012-09-18 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US9072662B2 (en) | 2004-03-29 | 2015-07-07 | Auris Medical Ag | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US20080241082A1 (en) * | 2004-04-05 | 2008-10-02 | Lonza Inc. | Method for the Preparation of Cosmetic Emulsion |
EP1755614A4 (en) * | 2004-04-08 | 2009-06-10 | Vela Pharmaceuticals Inc | Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome |
MXPA06012563A (en) * | 2004-04-29 | 2007-03-21 | Caldwell Galer Inc | Topical methadone compositions and methods for using the same. |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
WO2006022611A2 (en) * | 2004-06-26 | 2006-03-02 | Binnur Ozturk | Neuropathy cream |
US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US20070298089A1 (en) * | 2004-11-10 | 2007-12-27 | Masakazu Saeki | Drug for External Use and Adhesive Patch |
MX2007008279A (en) * | 2005-01-25 | 2008-02-15 | Epix Delaware Inc | Substituted arylamine compounds and their use as 5-ht6 modulators. |
DE102005004343A1 (en) * | 2005-01-25 | 2006-08-10 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Treatment of phantom phenomena |
CA2597651A1 (en) * | 2005-02-14 | 2006-08-24 | Neurogesx, Inc. | Device for delivery of trpv1 agonists |
US20060205789A1 (en) * | 2005-03-04 | 2006-09-14 | Neurosystec Corporation | Gacyclidine formulations |
WO2006102267A2 (en) * | 2005-03-21 | 2006-09-28 | The Trustees Of Columbia University In The City Of New York | New neuronal pain pathway |
US20060223788A1 (en) * | 2005-03-29 | 2006-10-05 | Cathcart Clifton H | Analgesic composition for topical use |
WO2006105481A1 (en) * | 2005-03-30 | 2006-10-05 | Neurogesx, Inc. | Low-concentration capsaicin patch and methods for treating neuropathic pain |
US20060223786A1 (en) * | 2005-04-01 | 2006-10-05 | Smith David J | Transdermal pain control method and device |
US20070027152A1 (en) * | 2005-07-27 | 2007-02-01 | Clark Kathleen L | Topical anti-pruritic compositions and methods of action of same |
US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
AU2005337107B2 (en) | 2005-09-28 | 2012-05-24 | Auris Medical Ag | Pharmaceutical compositions for the treatment of inner ear disorders |
WO2007062186A2 (en) * | 2005-11-21 | 2007-05-31 | The Board Of Trustees Of The University Of Alabama For And On Behalf Of The University Of Alabama | Methods of using small molecule compounds for neuroprotection |
US20070148194A1 (en) * | 2005-11-29 | 2007-06-28 | Amiji Mansoor M | Novel nanoemulsion formulations |
US20090306050A1 (en) * | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
WO2007103555A2 (en) * | 2006-03-08 | 2007-09-13 | Nuviance, Inc. | Transdermal drug delivery compositions and topical compositions for application on the skin |
KR20090004980A (en) * | 2006-04-18 | 2009-01-12 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic compositions comprising salicylic acid and ascorbic acid |
US20070248657A1 (en) * | 2006-04-25 | 2007-10-25 | Smith David J | Multi-compartment transdermal pain control device |
US20070270413A1 (en) * | 2006-05-22 | 2007-11-22 | N.V. Organon | Mirtazapine for the treatment of neuropathic pain |
TWI392670B (en) * | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain |
US20080014247A1 (en) * | 2006-06-30 | 2008-01-17 | Nucryst Pharmaceuticals | Metal-containing formulations and methods of use |
EP2117521B1 (en) | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
WO2008085711A1 (en) * | 2007-01-03 | 2008-07-17 | Konova | Synergy of sodium channel blockers and calcium channel blockers |
WO2008112661A2 (en) | 2007-03-09 | 2008-09-18 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
WO2008139484A2 (en) * | 2007-05-16 | 2008-11-20 | R. L. Fine Chem | New process for the synthesis of loferpramine maleate: a stable salt of loferpramine |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
WO2009000038A1 (en) * | 2007-06-28 | 2008-12-31 | Cnsbio Pty Ltd | Combination methods and compositions for treatment of neuropathic pain |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
ITMI20080316A1 (en) * | 2008-02-27 | 2009-08-28 | Aboca Spa | USE OF HYPERICUM PERFORATUM EXTRACTS IN THE TREATMENT OF NEUROPATHIC PAIN |
US20100104614A1 (en) * | 2008-06-27 | 2010-04-29 | Oronsky Bryan T | Providone compositions for wound healing |
EP2334176A4 (en) | 2008-09-27 | 2012-05-02 | Taraxos Inc | Topical formulations for treatment of neuropathy |
US8198268B2 (en) * | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
US20100221313A1 (en) * | 2008-12-01 | 2010-09-02 | Innovative Pharmaceuticals, Llc | Transdermal reservoir patch |
US8454877B2 (en) * | 2009-04-03 | 2013-06-04 | Pelican Products, Inc. | Method and apparatus for molding an article |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2011064631A1 (en) | 2009-10-02 | 2011-06-03 | Foamix Ltd. | Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
CA2782472C (en) * | 2009-12-15 | 2019-04-16 | The Hospital For Sick Children | Method of treating scars and beta-catenin-mediated disorders |
DE102010024105A1 (en) | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermal administration of memantine |
JP2013528632A (en) * | 2010-06-18 | 2013-07-11 | メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン | Gel formulations for topical use of 1-amino-alkylcyclohexane derivatives |
CN101966151B (en) * | 2010-09-06 | 2011-11-09 | 海南美大制药有限公司 | Trimipramine maleate liposome solid preparation |
SI3287123T1 (en) | 2011-03-04 | 2020-07-31 | Gruenenthal Gmbh | Aqueous pharmaceutical formulation of tapentadol for oral administration |
CA2850964C (en) * | 2011-10-05 | 2021-02-02 | Jennifer L. Sanders | Methods and compositions for treating foot or hand pain |
US9012486B2 (en) * | 2011-11-14 | 2015-04-21 | Alex Chervinsky | Topical composition for pain relief |
JP5941159B2 (en) | 2011-12-12 | 2016-06-29 | オトラーヌム アーゲー | Treatment of tinnitus by regulation of chloride ion symporter NKCC1 in the auditory system |
WO2013138520A1 (en) * | 2012-03-13 | 2013-09-19 | University Of Tennessee Research Foundation | Composition and system for transdermal delivery |
ES2484068B1 (en) * | 2013-02-08 | 2015-04-16 | Ana MÍNGUEZ MARTÍ | A pharmaceutical composition containing ketamine and amitriptyline |
EP2968270A4 (en) * | 2013-03-14 | 2016-08-17 | Univ California | Modulation of k2p channels |
US9597099B2 (en) | 2013-07-29 | 2017-03-21 | Covidien Lp | Energy-based treatment methods for refractory gout |
WO2015081007A1 (en) | 2013-11-26 | 2015-06-04 | Humco Holding Group, Inc. | Transdermal silicone gel (silogel) compositions and methods of preparation |
EP3134106A1 (en) * | 2014-02-24 | 2017-03-01 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Multivalent/multifunctional ligands with agonist activities at opioid receptors and antagonist activities at nk1 receptor for relief of pain |
EP2946776A1 (en) * | 2014-05-20 | 2015-11-25 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system for the release of amitriptylin |
US9012402B1 (en) | 2014-06-11 | 2015-04-21 | James Blanchard | Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation |
JP6891118B2 (en) | 2014-12-23 | 2021-06-18 | インテレクチュアル プロパティ アソシエイツ エルエルシーIntellectual Property Associates, LLC | Methods and formulations for transdermal administration |
PT3273953T (en) | 2015-03-27 | 2019-04-01 | Gruenenthal Gmbh | Stable formulation for parenteral administration of tapentadol |
US20160367491A1 (en) * | 2015-06-22 | 2016-12-22 | Johnson & Johnson Consumer Inc. | Method for providing a benefit to skin |
AU2016323977B9 (en) * | 2015-09-16 | 2021-03-04 | The Trustees Of Columbia University In The City Of New York | Carboxylic diarylthiazepineamines as mu-opioid receptor agonists |
WO2017070017A1 (en) * | 2015-10-23 | 2017-04-27 | Rush University Medical Center | Topical compositions providing pain relief and methods of use thereof |
US10004734B2 (en) | 2016-01-26 | 2018-06-26 | Warren Scherer | Compositions and methods for treating rebound erythema associated with topical alpha-adrenergic agonists |
WO2017173442A1 (en) * | 2016-04-01 | 2017-10-05 | Good Pharmaceutical Development Company, Llc | Topical compositions for neuropathic pain |
US10463699B2 (en) | 2016-04-04 | 2019-11-05 | Omeza LLC | Fish oil topical composition |
CN106243096B (en) * | 2016-07-29 | 2019-11-29 | 上海璃道医药科技有限公司 | The new application of tricyclic drugs |
MX2020012139A (en) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Compositions and methods for treating rosacea and acne. |
EA201990744A1 (en) | 2016-09-23 | 2019-08-30 | Грюненталь Гмбх | STABLE MEDICINAL FORM FOR Parenteral Administration of TAPENTADOL |
US11147799B2 (en) | 2016-12-06 | 2021-10-19 | Jan Marius Keppel Hesselink | Topical pharmaceutical composition containing phenytoin and a (co-) analgesic for the treatment of chronic pain |
FR3065371B1 (en) * | 2017-04-25 | 2021-05-21 | Laboratoires Mayoly Spindler | TOPICAL PHARMACEUTICAL COMPOSITION INCLUDING AT LEAST AMITRIPTYLINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN |
US10821075B1 (en) | 2017-07-12 | 2020-11-03 | James Blanchard | Compositions for topical application of a medicaments onto a mammalian body surface |
DE102017215154A1 (en) * | 2017-08-30 | 2019-02-28 | Markus Bläss | Composition for the topical treatment of non-microorganism-caused inflammatory skin and mucous membrane diseases |
WO2019055880A2 (en) | 2017-09-15 | 2019-03-21 | Ampersand Biopharmaceuticals, Inc. | Method of administration and treatment |
US10959975B1 (en) | 2017-11-02 | 2021-03-30 | The Tetra Corporation | Antifungal composition, method of making composition, and method of using composition |
WO2019112964A1 (en) * | 2017-12-04 | 2019-06-13 | Sienna Biopharmaceuticals, Inc. | Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure |
WO2020188457A1 (en) * | 2019-03-15 | 2020-09-24 | Ftf Pharma Private Limited | Solutions for oral dosage |
US11752114B2 (en) * | 2019-04-17 | 2023-09-12 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system |
PL430531A1 (en) * | 2019-07-09 | 2021-01-11 | Biotts Spółka Akcyjna | Substrate and pharmaceutical composition containing it |
FR3108841B1 (en) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE |
EP3949956A1 (en) * | 2020-08-06 | 2022-02-09 | LTS Lohmann Therapie-Systeme AG | Esketamine-suspension-tts |
CN114225039A (en) * | 2021-12-29 | 2022-03-25 | 中国科学院深圳先进技术研究院 | Antagonist composition and application thereof in preparation of medicine for treating sleep disorder and mental disease |
CN117384000A (en) * | 2022-07-05 | 2024-01-12 | 湖南洞庭药业股份有限公司 | Dibenzocycloheptadiene and application thereof in preparation of amitriptyline hydrochloride composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635204A (en) * | 1994-03-04 | 1997-06-03 | Montefiore Medical Center | Method for transdermal induction of anesthesia, analgesia or sedation |
US6461600B1 (en) * | 2000-07-19 | 2002-10-08 | Peter R. Ford | Topical pain relief composition and carrier |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79380B (en) | 1982-09-28 | 1984-10-22 | Johnson & Johnson Prod Inc | |
US4751087A (en) | 1985-04-19 | 1988-06-14 | Riker Laboratories, Inc. | Transdermal nitroglycerin delivery system |
US4615699A (en) | 1985-05-03 | 1986-10-07 | Alza Corporation | Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
US4755535A (en) | 1986-04-23 | 1988-07-05 | Nelson Research & Development Co. | Compositions comprising 1-substituted azacycloalkenes |
US4801586A (en) | 1986-04-23 | 1989-01-31 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agents |
US4808414A (en) | 1986-09-29 | 1989-02-28 | Nelson Research & Development Co. | Amide penetration enhancers for transdermal delivery of systemic agents |
US4920101A (en) | 1987-09-30 | 1990-04-24 | Nelson Research & Development Co. | Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes |
US4989607A (en) | 1989-03-30 | 1991-02-05 | Preston Keusch | Highly conductive non-stringy adhesive hydrophilic gels and medical electrode assemblies manufactured therefrom |
EP0424179A3 (en) | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
KR100353486B1 (en) | 1990-03-02 | 2003-01-06 | 스테이트 오브 오레곤,액팅 바이 앤드 쓰로우 디 오레곤 스테이트 보드 오브 하이어 에주케이션,액팅포앤드 온 비해프 오브 디 오레곤 헬쓰 사이언시즈 유니버시티 앤드 더 유니버시티 오브 오레곤,유진,오레곤 | Trisubstituted and tetrasubstituted guanidines and pharmaceutical compositions containing them |
US5708035A (en) | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
HUT74560A (en) * | 1991-10-16 | 1997-01-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
WO1993010163A2 (en) | 1991-11-12 | 1993-05-27 | Nepera, Inc. | Adhesive hydrogels having extended use lives and process for the preparation of same |
IL106142A (en) | 1992-06-29 | 1997-03-18 | Merck & Co Inc | Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them |
US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
PL175831B1 (en) | 1992-12-17 | 1999-02-26 | Pfizer | Pyrazoles and prazolopyrimidines exhibiting antagonistic activity in respect to crf |
KR19990067704A (en) | 1992-12-17 | 1999-08-25 | 디. 제이. 우드, 스피겔 알렌 제이 | Pharmaceutical composition containing pyrrolopyrimidine as an adrenal cortical stimulating hormone free factor antagonist |
ATE187451T1 (en) | 1992-12-17 | 1999-12-15 | Pfizer | SUBSTITUTED PYRAZOLES AS CRF ANTAGONISTS |
TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
TW444018B (en) | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
CA2159106C (en) | 1993-04-20 | 2009-10-06 | Lorrie P. Daggett | Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
US5631373A (en) | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
US5612337A (en) | 1993-12-29 | 1997-03-18 | Merck Sharp & Dohme Limited | Substituted morpholine derivatives and their use as therapeutic agents |
JPH09510695A (en) | 1994-01-03 | 1997-10-28 | エイシア・ファーマシュウティカルズ,インコーポレイテッド | 8-Aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and their use as antagonists to the glycine / NMDA receptor |
IL112778A0 (en) | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
US5962477A (en) | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
CZ290961B6 (en) | 1994-08-30 | 2002-11-13 | Sankyo Company, Limited | Isoxazole derivatives process of their preparation and intermediate therefor |
US5476933A (en) | 1994-11-16 | 1995-12-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Azepine synthesis via a diels-alder reaction |
US5948389A (en) | 1995-06-07 | 1999-09-07 | El Khoury & Stein, Ltd. | Method of enhancing the analgesic efficacy of locally and topically administered opioids and other local anesthetics |
US6197830B1 (en) | 1995-09-22 | 2001-03-06 | Bruce M. Frome | Method for achieving relief from sympathetically mediated pain |
AU738304B2 (en) | 1995-10-13 | 2001-09-13 | Neurogen Corporation | Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands |
IN184685B (en) | 1996-02-14 | 2000-09-23 | Nat Inst Immunology | |
US5646151A (en) | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5688955A (en) | 1996-03-08 | 1997-11-18 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US5888494A (en) | 1996-03-12 | 1999-03-30 | Adolor Corporation | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
US5667773A (en) | 1996-03-12 | 1997-09-16 | Adolor Corporation | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith |
US6025369A (en) | 1996-05-03 | 2000-02-15 | The Board Of Regents Of The University Nebraska | N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
US6191165B1 (en) | 1996-05-31 | 2001-02-20 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
EP0927171B1 (en) | 1996-09-16 | 2002-02-20 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
US6117855A (en) | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
US5798093A (en) | 1997-03-14 | 1998-08-25 | Adolor Corporation | Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
US5811078A (en) | 1997-03-14 | 1998-09-22 | Adolor Corporation | Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith |
US5817699A (en) | 1997-05-30 | 1998-10-06 | Flores; John A. | Process for the preparation of ketamine ointment |
US5783700A (en) | 1997-07-03 | 1998-07-21 | Nichols; Alfred C. | Quinolic acid derivatives |
US5849762A (en) | 1997-07-14 | 1998-12-15 | Adolor Corporation | Peripherally acting anti-pruritic opiates |
EP0996434A4 (en) | 1997-07-14 | 2001-10-10 | Adolor Corp | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
US5760023A (en) | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
JP3393991B2 (en) | 1997-08-29 | 2003-04-07 | タイコエレクトロニクスアンプ株式会社 | Card connector |
DE19818924A1 (en) | 1998-04-28 | 1999-11-04 | Degussa | Surface-modified fillers, processes for their production and their use |
US6211171B1 (en) * | 1998-05-19 | 2001-04-03 | Dalhousie University | Use of antidepressants for local analgesia |
US6255302B1 (en) | 1998-12-17 | 2001-07-03 | American Home Products Corporation | 1,4-piperazine derivatives |
US6242448B1 (en) | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
FR2787450B1 (en) | 1998-12-18 | 2001-01-26 | Adir | NOVEL SPIROIMIDAZOLINIC DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
AU771234B2 (en) | 1999-01-28 | 2004-03-18 | Bristol-Myers Squibb Company | Antidepressant heterocyclic compounds |
GB9904163D0 (en) * | 1999-02-23 | 1999-04-14 | Bioglan Lab Ltd | Pharmaceutical compositions |
US6017961A (en) | 1999-07-08 | 2000-01-25 | Flores; John Anthony | Ketamine and n-butyl-p-aminobezoate in PLO |
-
2001
- 2001-08-17 US US09/931,293 patent/US6638981B2/en not_active Expired - Lifetime
-
2002
- 2002-08-14 IL IL16038802A patent/IL160388A0/en unknown
- 2002-08-14 CN CNB028201124A patent/CN100496472C/en not_active Expired - Fee Related
- 2002-08-14 KR KR10-2004-7002327A patent/KR20040053112A/en not_active Application Discontinuation
- 2002-08-14 MX MXPA04001368A patent/MXPA04001368A/en active IP Right Grant
- 2002-08-14 JP JP2003520460A patent/JP2005501844A/en active Pending
- 2002-08-14 WO PCT/US2002/025871 patent/WO2003015699A2/en active Application Filing
- 2002-08-14 NZ NZ531547A patent/NZ531547A/en not_active IP Right Cessation
- 2002-08-14 CA CA2457780A patent/CA2457780C/en not_active Expired - Fee Related
- 2002-08-14 EP EP02770398A patent/EP1438020A4/en not_active Withdrawn
- 2002-08-14 AR ARP020103069A patent/AR035131A1/en unknown
- 2002-08-14 AU AU2002335635A patent/AU2002335635B2/en not_active Ceased
-
2003
- 2003-09-25 US US10/669,258 patent/US20040076648A1/en not_active Abandoned
-
2004
- 2004-02-12 IL IL160388A patent/IL160388A/en not_active IP Right Cessation
-
2006
- 2006-09-01 HK HK06109763.0A patent/HK1089364A1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635204A (en) * | 1994-03-04 | 1997-06-03 | Montefiore Medical Center | Method for transdermal induction of anesthesia, analgesia or sedation |
US6461600B1 (en) * | 2000-07-19 | 2002-10-08 | Peter R. Ford | Topical pain relief composition and carrier |
Non-Patent Citations (1)
Title |
---|
MICHALUN NATALIA ET AL.: "Milady's Skin Care and Cosmetic Ingredients Dictionary", 1994, pages: 243, XP002962260 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
Also Published As
Publication number | Publication date |
---|---|
US20030082214A1 (en) | 2003-05-01 |
EP1438020A2 (en) | 2004-07-21 |
CA2457780A1 (en) | 2003-02-27 |
MXPA04001368A (en) | 2005-06-06 |
NZ531547A (en) | 2006-08-31 |
US20040076648A1 (en) | 2004-04-22 |
JP2005501844A (en) | 2005-01-20 |
AU2002335635B2 (en) | 2008-06-05 |
WO2003015699A2 (en) | 2003-02-27 |
IL160388A0 (en) | 2004-07-25 |
KR20040053112A (en) | 2004-06-23 |
US6638981B2 (en) | 2003-10-28 |
EP1438020A4 (en) | 2010-01-13 |
IL160388A (en) | 2010-02-17 |
CA2457780C (en) | 2010-10-26 |
CN1747719A (en) | 2006-03-15 |
HK1089364A1 (en) | 2006-12-01 |
CN100496472C (en) | 2009-06-10 |
AR035131A1 (en) | 2004-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003015699A3 (en) | Topical compositions and methods for treating pain | |
ATE356606T1 (en) | ANTI-ITCH COSMETIC AND DERMATOLOGICAL PREPARATIONS | |
WO2002055055A3 (en) | Fast-acting antimicrobial lotion with enhanced efficacy | |
BR0314354A (en) | Formation for lipophilic people | |
CL2013000862A1 (en) | Synergistic combinations of fungicidal active products containing carboxamide and at least one compound selected from metalaxil-m and benalaxil-m; use for the fight against unwanted phytopathogenic fungi. (divisional of sun. n ° 2729-2004) | |
WO2003053383A3 (en) | Cosmetic use of at least a hydrophobin for treating keratinous materials | |
ZA200102441B (en) | Cntrolled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues. | |
WO2002072031A3 (en) | Substituted tetracycline compounds as synergistic antifungal agents | |
WO2002076413A3 (en) | Skin care compositions | |
WO2007029152A3 (en) | Solid skin care composition comprising multiple layers | |
EP1190696A3 (en) | Hair cosmetic compositions and use thereof | |
FR2856294B1 (en) | COSMETIC USE OF A COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT, AS SLIMMING AND / OR FOR PREVENTING AND / OR TREATING CELLULITE | |
EP1192938A3 (en) | Composition to enhance permeation of topical skin agents | |
WO2002028810A3 (en) | Retinoids for the treatment of emphysema | |
MY122877A (en) | Composition. | |
NO20035458D0 (en) | Active ingredient combination of, for example, galantamine or deoxypeganine and, for example, acamprosate or memantine for the treatment of addiction such as alcoholism | |
WO2004058162A3 (en) | Oil absorbent topical compositions and methods for using same | |
WO2001091703A3 (en) | Low emulsifier multiple emulsions | |
AU2002366451A1 (en) | Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol | |
AU2002250150A1 (en) | Demulsifier for aqueous completion fluids | |
MY136239A (en) | Emulsions having minimal rub-in times | |
MXPA05001074A (en) | Emulsified water/hydrocarbon fuel, preparation and uses thereof. | |
ATE502619T1 (en) | SOLID OIL-IN-WATER EMULSION SUITABLE FOR COSMETICS | |
WO2005053394A3 (en) | Synergistic insecticide mixtures | |
BR0115983A (en) | Use of sarp-1 for the treatment and / or prevention of scleroderma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 160388 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/001368 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003520460 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2457780 Country of ref document: CA Ref document number: 1020047002327 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002335635 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 531547 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002770398 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028201124 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002770398 Country of ref document: EP |